Eukaryotic elongation factor-2 kinase (eEF2K) signaling in tumor and microenvironment as a novel molecular target
The DOI matches its Crossref record; 122 of the 122 references it cites were found in a registry or an index.
Abstract
Eukaryotic elongation factor-2 kinase (eEF2K), an atypical member of alpha-kinase family, is highly overexpressed in breast, pancreatic, brain, and lung cancers, and associated with poor survival in patients. eEF2K promotes cell proliferation, survival, and aggressive tumor characteristics, leading to tumor growth and progression. While initial studies indicated that eEF2K acts as a negative regulator of protein synthesis by suppressing peptide elongation phase, later studies demonstrated that it has multiple functions and promotes cell cycle, angiogenesis, migration, and invasion as well as induction of epithelial-mesenchymal transition through induction of integrin β1, SRC/FAK, PI3K/AKT, cyclin D1, VEGF, ZEB1, Snail, and MMP-2. Under stress conditions such as hypoxia and metabolic distress, eEF2K is activated by several signaling pathways and slows down protein synthesis and helping cells to save energy and survive. In vivo therapeutic targeting of eEF2K by genetic methods inhibits tumor growth in various tumor models, validating it as a potential molecular target. Recent studies suggest that eEF2K plays a role in tumor microenvironment cells by monocyte chemoattractant protein-1 (MCP-1) and accumulation of tumor-associated macrophages. Due to its clinical significance and the pivotal role in tumorigenesis and progression, eEF2K is considered as an important therapeutic target in solid tumors. However, currently, there is no specific and potent inhibitor for translation into clinical studies. Here, we aim to systematically review current knowledge regarding eEF2K in tumor biology, microenvironment, and development of eEF2K targeted inhibitors and therapeutics.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“eEF2K signaling intersects with excitation inhibition balance and circuit level plasticity, suggesting strong synergy with circuit specific interventions [159,160,164].”
From Synaptic Plasticity—Intrinsic Excitability and Antidepressant Discovery (2026) · cites this paper as [164]
Citations
Cites
Repertoires of Autophagy in the Pathogenesis of Ocular Diseases
Li, Y.-J., Jiang, Q., Cao, G.-F., Yao, J., & Yan, B. (2015) · Cellular Physiology and Biochemistry · doi:10.1159/000373980 · Cited by 16,304
MicroRNA expression profiles classify human cancers
Lu, J., Getz, G., Miska, E. A., Alvarez-Saavedra, E., Lamb, J., Peck, D., Sweet-Cordero, A., Ebert, B. L., Mak, R. H., Ferrando, A. A., et al. (2005) · Nature · doi:10.1038/nature03702 · Cited by 9,539
mTOR Signaling in Growth Control and Disease
Laplante, M., & Sabatini, D. M. (2012) · Cell · doi:10.1016/j.cell.2012.03.017 · Cited by 8,509
Microenvironmental regulation of tumor progression and metastasis
Quail, D. F., & Joyce, J. A. (2013) · Nature Medicine · doi:10.1038/nm.3394 · Cited by 7,994
MicroRNA signatures in human cancers
Calin, G. A., & Croce, C. M. (2006) · Nature Reviews Cancer · doi:10.1038/nrc1997 · Cited by 7,590
AMPK and mTOR regulate autophagy through direct phosphorylation of Ulk1
Kim, J., Kundu, M., Viollet, B., & Guan, K.-L. (2011) · Nature Cell Biology · doi:10.1038/ncb2152 · Cited by 7,227
Oncomirs—MicroRNAs with a role in cancer
Esquela-Kerscher, A., & Slack, F. J. (2006) · Nature Reviews Cancer · doi:10.1038/nrc1840 · Cited by 5,884
Accessories to the Crime: Functions of Cells Recruited to the Tumor Microenvironment
Hanahan, D., & Coussens, L. M. (2012) · Cancer Cell · doi:10.1016/j.ccr.2012.02.022 · Cited by 4,632
Tumour-associated macrophages as treatment targets in oncology
Mantovani, A., Marchesi, F., Malesci, A., Laghi, L., & Allavena, P. (2017) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2016.217 · Cited by 4,033
Macrophage plasticity and interaction with lymphocyte subsets: cancer as a paradigm
Biswas, S. K., & Mantovani, A. (2010) · Nature Immunology · doi:10.1038/ni.1937 · Cited by 3,840
Regulation mechanisms and signaling pathways of autophagy
He, C., & Klionsky, D. J. (2009) · Annual Review of Genetics · doi:10.1146/annurev-genet-102808-114910 · Cited by 3,609
The Versatile Role of microRNA-30a in Human Cancer
Wang, C., Yang, X., Chen, Y., & Chen, L. (2017) · Cellular Physiology and Biochemistry · doi:10.1159/000471111 · Cited by 3,409
Specificity and mechanism of action of some commonly used protein kinase inhibitors
DAVIES, S. P., REDDY, H., CAIVANO, M., & COHEN, P. (2000) · Biochemical Journal · doi:10.1042/bj3510095 · Cited by 3,132
The AMPK signalling pathway coordinates cell growth, autophagy and metabolism
Mihaylova, M. M., & Shaw, R. J. (2011) · Nature Cell Biology · doi:10.1038/ncb2329 · Cited by 2,923
Oxidative stress and autophagy: The clash between damage and metabolic needs
Filomeni, G., De Zio, D., & Cecconi, F. (2015) · Cell Death & Differentiation · doi:10.1038/cdd.2014.150 · Cited by 2,195
The tumor microenvironment at a glance
Balkwill, F. R., Capasso, M., & Hagemann, T. (2012) · Journal of Cell Science · doi:10.1242/jcs.116392 · Cited by 1,857
Interfering with pH regulation in tumours as a therapeutic strategy
Neri, D., & Supuran, C. T. (2011) · Nature Reviews Drug Discovery · doi:10.1038/nrd3554 · Cited by 1,547
The origin and function of tumor-associated macrophages
Mantovani, A., Bottazzi, B., Colotta, F., Sozzani, S., & Ruco, L. (1992) · Immunology Today · doi:10.1016/0167-5699(92)90008-u · Cited by 1,089
Making new contacts: the mTOR network in metabolism and signalling crosstalk
Shimobayashi, M., & Hall, M. N. (2014) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3757 · Cited by 1,053
Clinical relevance of circulating cell-free microRNAs in cancer
Schwarzenbach, H., Nishida, N., Calin, G. A., & Pantel, K. (2014) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2014.5 · Cited by 969
Mitchem, J. B., Brennan, D. J., Knolhoff, B. L., Belt, B. A., Zhu, Y., Sanford, D. E., Belaygorod, L., Carpenter, D., Collins, L., Piwnica-Worms, D., et al. (2013) · Cancer Research · doi:10.1158/0008-5472.can-12-2731 · Cited by 943
AMPK: An Energy-Sensing Pathway with Multiple Inputs and Outputs
Hardie, D. G., Schaffer, B. E., & Brunet, A. (2016) · Trends in Cell Biology · doi:10.1016/j.tcb.2015.10.013 · Cited by 859
Rottlerin, a Novel Protein Kinase Inhibitor
Gschwendt, M., Muller, H. J., Kielbassa, K., Zang, R., Kittstein, W., Rincke, G., & Marks, F. (1994) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1994.1199 · Cited by 841
Regulation of elongation factor 2 kinase by p90RSK1 and p70 S6 kinase
Wang, X. (2001) · The EMBO Journal · doi:10.1093/emboj/20.16.4370 · Cited by 796
Tumor microenvironment: Sanctuary of the devil
Hui, L., & Chen, Y. (2015) · Cancer Letters · doi:10.1016/j.canlet.2015.07.039 · Cited by 779
New horizons in tumor microenvironment biology: challenges and opportunities
Chen, F., Zhuang, X., Lin, L., Yu, P., Wang, Y., Shi, Y., Hu, G., & Sun, Y. (2015) · BMC Medicine · doi:10.1186/s12916-015-0278-7 · Cited by 704
MicroRNA function: Multiple mechanisms for a tiny RNA?: FIGURE 1.
PILLAI, R. S. (2005) · RNA · doi:10.1261/rna.2248605 · Cited by 681
Kitamura, T., Qian, B.-Z., Soong, D., Cassetta, L., Noy, R., Sugano, G., Kato, Y., Li, J., & Pollard, J. W. (2015) · Journal of Experimental Medicine · doi:10.1084/jem.20141836 · Cited by 651
The autophagy initiating kinase ULK1 is regulated via opposing phosphorylation by AMPK and mTOR
Egan, D., Kim, J., Shaw, R. J., & Guan, K.-L. (2011) · Autophagy · doi:10.4161/auto.7.6.15123 · Cited by 627
mTORC1 as the main gateway to autophagy
Rabanal-Ruiz, Y., Otten, E. G., & Korolchuk, V. I. (2017) · Essays in Biochemistry · doi:10.1042/ebc20170027 · Cited by 573
Phosphorylation of elongation factor 2 by EF-2 kinase affects rate of translation
Ryazanov, A. G., Shestakova, E. A., & Natapov, P. G. (1988) · Nature · doi:10.1038/334170a0 · Cited by 454
Tumor-associated macrophages: unwitting accomplices in breast cancer malignancy
Williams, C. B., Yeh, E. S., & Soloff, A. C. (2016) · npj Breast Cancer · doi:10.1038/npjbcancer.2015.25 · Cited by 444
The eEF2 Kinase Confers Resistance to Nutrient Deprivation by Blocking Translation Elongation
Leprivier, G., Remke, M., Rotblat, B., Dubuc, A., Mateo, A.-R. F., Kool, M., Agnihotri, S., El-Naggar, A., Yu, B., Prakash Somasekharan, S., et al. (2013) · Cell · doi:10.1016/j.cell.2013.04.055 · Cited by 414
Nutrient signaling to mTOR and cell growth
Jewell, J. L., & Guan, K.-L. (2013) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2013.01.004 · Cited by 410
Browne, G. J., Finn, S. G., & Proud, C. G. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m309773200 · Cited by 353 · cited 2×
“Phosphorylation of eEF2K at Ser78, Ser359, and Ser366 caused suppression of its activity (reduced p-eEF2 levels), leading to increased protein synthesis, while phosphorylation at Ser392, Ser398, and Ser499 residues results in its activation and reduced protein synthesis.”
BackgroundmTORC1-mediated translational elongation limits intestinal tumour initiation and growth
Faller, W. J., Jackson, T. J., Knight, J. R. P., Ridgway, R. A., Jamieson, T., Karim, S. A., Jones, C., Radulescu, S., Huels, D. J., Myant, K. B., et al. (2015) · Nature · doi:10.1038/nature13896 · Cited by 302
Cross-Talk between AMPK and mTOR in Regulating Energy Balance
Xu, J., Ji, J., & Yan, X.-H. (2012) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2010.500245 · Cited by 299
AMP-activated protein kinase: maintaining energy homeostasis at the cellular and whole-body levels
Hardie, D. G. (2014) · Annual Review of Nutrition · doi:10.1146/annurev-nutr-071812-161148 · Cited by 281
Yamaguchi, H., Matsushita, M., Nairn, A. C., & Kuriyan, J. (2001) · Molecular Cell · doi:10.1016/s1097-2765(01)00256-8 · Cited by 278
Nerve–Cancer Cell Cross-talk: A Novel Promoter of Tumor Progression
Jobling, P., Pundavela, J., Oliveira, S. M. R., Roselli, S., Walker, M. M., & Hondermarck, H. (2015) · Cancer Research · doi:10.1158/0008-5472.can-14-3180 · Cited by 272
Redpath, N. T., Foulstone, E. J., & Proud, C. G. (1996) · The EMBO Journal · doi:10.1002/j.1460-2075.1996.tb00582.x · Cited by 262
FOXM1: An emerging master regulator of DNA damage response and genotoxic agent resistance
Zona, S., Bella, L., Burton, M. J., Nestal de Moraes, G., & Lam, E. W.-F. (2014) · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms · doi:10.1016/j.bbagrm.2014.09.016 · Cited by 225
Multiple amino acid sensing inputs to mTORC1
Shimobayashi, M., & Hall, M. N. (2016) · Cell Research · doi:10.1038/cr.2015.146 · Cited by 223
Connolly, E., Braunstein, S., Formenti, S., & Schneider, R. J. (2006) · Molecular and Cellular Biology · doi:10.1128/mcb.26.10.3955-3965.2006 · Cited by 219
Roles of microRNA on cancer cell metabolism
Chen, B., Li, H., Zeng, X., Yang, P., Liu, X., Zhao, X., & Liang, S. (2012) · Journal of Translational Medicine · doi:10.1186/1479-5876-10-228 · Cited by 203
Eukaryotic elongation factor 2 kinase, an unusual enzyme with multiple roles
Kenney, J. W., Moore, C. E., Wang, X., & Proud, C. G. (2014) · Advances in Biological Regulation · doi:10.1016/j.jbior.2014.04.003 · Cited by 182
Alpha-kinases: a new class of protein kinases with a novel catalytic domain
Ryazanov, A. G., Pavur, K. S., & Dorovkov, M. V. (1999) · Current Biology · doi:10.1016/s0960-9822(99)80006-2 · Cited by 178
α4 Is an Essential Regulator of PP2A Phosphatase Activity
Kong, M., Ditsworth, D., Lindsten, T., & Thompson, C. B. (2009) · Molecular Cell · doi:10.1016/j.molcel.2009.09.025 · Cited by 162 · cited 12×
“AMPK and glycogen synthase kinase 3 (GSK3) are known as the positive regulators of eEF2K activity.”
BackgroundInfluentialThe B55α Subunit of PP2A Drives a p53-Dependent Metabolic Adaptation to Glutamine Deprivation
Reid, M. A., Wang, W.-I., Rosales, K. R., Welliver, M. X., Pan, M., & Kong, M. (2013) · Molecular Cell · doi:10.1016/j.molcel.2013.02.008 · Cited by 154
Cross-talk between protein synthesis, energy metabolism and autophagy in cancer
Lindqvist, L., Tandoc, K. V., Topisirović, I., & Furic, L. (2017) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2017.11.003 · Cited by 154
Ca2+/calmodulin‐dependent phosphorylation of elongation factor 2
Ryazanov, A. G. (1987) · FEBS Letters · doi:10.1016/0014-5793(87)80081-9 · Cited by 150
How cancer cells dictate their microenvironment: present roles of extracellular vesicles
Naito, Y., Yoshioka, Y., Yamamoto, Y., & Ochiya, T. (2017) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-016-2346-3 · Cited by 148
Tumor–Microenvironment Interactions: Dangerous Liaisons
Witz, I. P. (2008) · Advances in cancer research · doi:10.1016/s0065-230x(08)00007-9 · Cited by 147
Elongation Factor-2 Kinase Regulates Autophagy in Human Glioblastoma Cells
Wu, H., Yang, J.-M., Jin, S., Zhang, H., & Hait, W. N. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-1554 · Cited by 143
Bayraktar, R., Pichler, M., Kanlikilicer, P., Ivan, C., Bayraktar, E., Kahraman, N., Aslan, B., Oguztuzun, S., Ulasli, M., Arslan, A., et al. (2017) · Oncotarget · doi:10.18632/oncotarget.14264 · Cited by 138
Cheng, Y., Ren, X., Zhang, Y., Patel, R., Sharma, A., Wu, H., Robertson, G. P., Yan, L., Rubin, E., & Yang, J.-M. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-2889 · Cited by 135
Fang, W. B., Yao, M., Brummer, G., Acevedo, D., Alhakamy, N. A., Berkland, C. J., & Cheng, N. (2016) · Oncotarget · doi:10.18632/oncotarget.9885 · Cited by 131
Hamurcu, Z., Delibaşı, N., Geçene, S., Şener, E. F., Dönmez‐Altuntaş, H., Özkul, Y., Canatan, H., & Özpolat, B. (2017) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-017-2557-5 · Cited by 129
Tissue Transglutaminase Inhibits Autophagy in Pancreatic Cancer Cells
Akar, U., Ozpolat, B., Mehta, K., Fok, J., Kondo, Y., & Lopez-Berestein, G. (2007) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-06-0229 · Cited by 123
The Nature of Neural Invasion by Pancreatic Cancer
Kayahara, M., Nakagawara, H., Kitagawa, H., & Ohta, T. (2007) · Pancreas · doi:10.1097/mpa.0b013e3180619677 · Cited by 121
Cholinergic innervation and function in the prostate gland
Ventura, S., Pennefather, J. N., & Mitchelson, F. J. (2002) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(02)00174-2 · Cited by 118
Hamurcu, Z., Ashour, A. A., Kahraman, N., & Özpolat, B. (2016) · Oncotarget · doi:10.18632/oncotarget.7672 · Cited by 118
Tekedereli, I., Alpay, S. N., Tavares, C. D. J., Cobanoglu, Z. E., Kaoud, T. S., Sahin, I., Sood, A. K., Lopez-Berestein, G., Dalby, K. N., & Ozpolat, B. (2012) · PLoS ONE · doi:10.1371/journal.pone.0041171 · Cited by 117
Liu, R., & Proud, C. G. (2016) · Acta Pharmacologica Sinica · doi:10.1038/aps.2015.123 · Cited by 117
Chen, Z., Gopalakrishnan, S. M., Bui, M.-H., Soni, N. B., Warrior, U., Johnson, E. F., Donnelly, J. B., & Glaser, K. B. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.301291 · Cited by 115
Wu, H., Zhu, H., Liu, D. X., Niu, T.-K., Ren, X., Patel, R., Hait, W. N., & Yang, J. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-2872 · Cited by 101
Role of the nervous system in cancer metastasis
Li, S., Sun, Y., & GAO, D. (2013) · Oncology Letters · doi:10.3892/ol.2013.1168 · Cited by 100
Wang, X., Regufe da Mota, S., Liu, R., Moore, C. E., Xie, J., Lanucara, F., Agarwala, U., Pyr dit Ruys, S., Vertommen, D., Rider, M. H., et al. (2014) · Molecular and Cellular Biology · doi:10.1128/mcb.01035-14 · Cited by 100
Targeting elongation factor-2 kinase (eEF-2K) induces apoptosis in human pancreatic cancer cells
Ashour, A. A., Abdel‐Aziz, A. H., Mansour, A. M., Alpay, S. N., Huo, L., & Özpolat, B. (2013) · APOPTOSIS · doi:10.1007/s10495-013-0927-2 · Cited by 97
Molecular mechanisms of mTOR regulation by stress
Heberle, A. M., Prentzell, M. T., van Eunen, K., Bakker, B. M., Grellscheid, S. N., & Thedieck, K. (2015) · Molecular & Cellular Oncology · doi:10.4161/23723548.2014.970489 · Cited by 97
Regulation and roles of elongation factor 2 kinase
Proud, C. G. (2015) · Biochemical Society Transactions · doi:10.1042/bst20140323 · Cited by 96
Xie, C.-M., Liu, X.-Y., Sham, K. W., Lai, J. M., & Cheng, C. H. (2014) · Autophagy · doi:10.4161/auto.29164 · Cited by 94
Arora, S., Yang, J., Kinzy, T. G., Utsumi, R., Okamoto, T., Kitayama, T., Ortiz, P. A., & Hait, W. N. (2003) · PubMed · Cited by 92
Gschwendt, M., Kittstein, W., & Marks, F. (1994) · FEBS Letters · doi:10.1016/0014-5793(94)80121-5 · Cited by 92
Pinto, J. A., Rolfo, C. D., Raez, L. E., Prado-Mantilla, A., Araujo, J. M., Bravo, L., Fajardo, W., Morante, Z., Aguilar, A., Neciosup, S. P., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-01207-3 · Cited by 90
Bayraktar, R., Ivan, C., Bayraktar, E., Kanlikilicer, P., Kabil, N. N., Kahraman, N., Mokhlis, H. A., Karakaş, D., Rodriguez‐Aguayo, C., Arslan, A., et al. (2018) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-17-1959 · Cited by 87
Ashour, A. A., Gürbüz, N., Alpay, S. N., Abdel‐Aziz, A. H., Mansour, A. M., Huo, L., & Özpolat, B. (2014) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.12361 · Cited by 85
Eukaryotic Elongation Factor 2 Kinase (eEF2K) in Cancer
Wang, X., Xie, J., & Proud, C. G. (2017) · Cancers · doi:10.3390/cancers9120162 · Cited by 85
Cheng, Y., Ren, X., Zhang, Y., Shan, Y., Huber-Keener, K. J., Zhang, L., Kimball, S. R., Harvey, H. A., Jefferson, L. S., & Yang, J.-M. (2013) · Autophagy · doi:10.4161/auto.22801 · Cited by 82
Sun, D., Zhu, L., Zhao, Y., Jiang, Y., Chen, L., Yu, Y., & Ouyang, L. (2017) · Cell Proliferation · doi:10.1111/cpr.12402 · Cited by 80
Johanns, M., Ruys, S. P. D., Houddane, A., Vertommen, D., Herinckx, G., Hue, L., Proud, C. G., & Rider, M. H. (2017) · Cellular Signalling · doi:10.1016/j.cellsig.2017.05.010 · Cited by 79
Diggle, T. A., Subkhankulova, T., Lilley, K. S., SHIKOTRA, N., Willis, A. E., & Redpath, N. T. (2001) · Biochemical Journal · doi:10.1042/0264-6021:3530621 · Cited by 77
Huang, L., Xu, A., & Liu, W. (2015) · Europe PMC (PubMed Central) · Cited by 77
Elongation Factor 2 Kinase Is Regulated by Proline Hydroxylation and Protects Cells during Hypoxia
Moore, C. E. J., Mikolajek, H., Regufe da Mota, S., Wang, X., Kenney, J. W., Werner, J. M., & Proud, C. G. (2015) · Molecular and Cellular Biology · doi:10.1128/mcb.01457-14 · Cited by 68
Inhibition of eEF2-K by thieno[2,3-b]pyridine analogues
Lockman, J. W., Reeder, M. D., Suzuki, K., Ostanin, K., Hoff, R., Bhoite, L. T., Austin, H., Baichwal, V. R., & Willardsen, J. A. (2010) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2010.02.005 · Cited by 65
Cho, S. I., Koketsu, M., Ishihara, H., Matsushita, M., Nairn, A. C., Fukazawa, H., & Uehara, Y. (2000) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/s0304-4165(00)00061-1 · Cited by 63
Tavares, C. D. J., O’Brien, J. P., Abramczyk, O., Devkota, A. K., Shores, K. S., Ferguson, S. B., Kaoud, T. S., Warthaka, M., Marshall, K. D., Keller, K. M., et al. (2012) · Biochemistry · doi:10.1021/bi201788e · Cited by 62
Hori, H., Nagasawa, H., Ishibashi, M., Uto, Y., Hirata, A., Saijo, K., Ohkura, K., Kirk, K. L., & Uehara, Y. (2002) · Bioorganic & Medicinal Chemistry · doi:10.1016/s0968-0896(02)00160-8 · Cited by 60
Identification of autophosphorylation sites in eukaryotic elongation factor-2 kinase
Pyr Dit Ruys, S., Wang, X., Smith, E. M., Herinckx, G., Hussain, N., Rider, M. H., Vertommen, D., & Proud, C. G. (2012) · Biochemical Journal · doi:10.1042/bj20111530 · Cited by 59
Devkota, A. K., Tavares, C. D. J., Warthaka, M., Abramczyk, O., Marshall, K. D., Kaoud, T. S., Gorgulu, K., Ozpolat, B., & Dalby, K. N. (2012) · Biochemistry · doi:10.1021/bi201787p · Cited by 58
Zhou, Y., Li, Y., Xu, S., Lü, J., Zhu, Z., Chen, S., Tan, Y., He, P., Xu, J., Proud, C. G., et al. (2019) · International Journal of Cancer · doi:10.1002/ijc.32560 · Cited by 58
Diggle, T. A., Subkhankulova, T., Lilley, K. S., et al. (2001) · Biochemical Journal · doi:10.1042/bj3530621 · Cited by 56
Analysis of the domain structure of elongation factor‐2 kinase by mutagenesis
Diggle, T. A., Seehra, C. K., Hase, S., & Redpath, N. T. (1999) · FEBS Letters · doi:10.1016/s0014-5793(99)01034-0 · Cited by 53
Crystal Structure of the α-Kinase Domain of Dictyostelium Myosin Heavy Chain Kinase A
Ye, Q., Crawley, S. W., Yang, Y., Côté, G. P., & Jia, Z. (2010) · Science Signaling · doi:10.1126/scisignal.2000525 · Cited by 51
Nerve fibers in tumors of the human urinary bladder
Seifert, P., Benedic, M., & Effert, P. J. (2001) · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · doi:10.1007/s004280100496 · Cited by 50
Moore, C. E., Xuemin, W., Xie, J., Pickford, J., Barron, J., da Mota, S. R., Versele, M., & Proud, C. G. (2016) · Cellular Signalling · doi:10.1016/j.cellsig.2016.01.005 · Cited by 49
Tian, W., Wang, L., Yuan, L., Duan, W., Zhao, W., Wang, S., & Zhang, Q. (2016) · Cancer Science · doi:10.1111/cas.12964 · Cited by 49
Pigott, C. R., Mikolajek, H., Moore, C. E., Finn, S. J., Phippen, C. W., Werner, J. M., & Proud, C. G. (2012) · Biochemical Journal · doi:10.1042/bj20111536 · Cited by 48
Bircan, A., Gürbüz, N., Pataer, A., Caner, A., Kahraman, N., Bayraktar, E., Bayraktar, R., Erdoğan, M. A., Kabil, N. N., & Özpolat, B. (2018) · Lung Cancer · doi:10.1016/j.lungcan.2018.07.027 · Cited by 48
Xie, J., Mikolajek, H., Pigott, C. R., Hooper, K. J., Mellows, T., Moore, C. E., Mohammed, H., Werner, J. M., Thomas, G. J., & Proud, C. G. (2015) · Molecular and Cellular Biology · doi:10.1128/mcb.00012-15 · Cited by 47
Pharmacological eEF2K activation promotes cell death and inhibits cancer progression
Gassart, A. D., Demaria, O., Panès, R., Zaffalon, L., Ryazanov, A. G., Gilliet, M. F., & Martinon, F. (2016) · EMBO Reports · doi:10.15252/embr.201642194 · Cited by 47
eEF2K promotes progression and radioresistance of esophageal squamous cell carcinoma
Zhu, H., Song, H., Chen, G., Yang, X., Liu, J., Ge, Y., Lü, J., Qin, Q., Zhang, C., Xu, L., et al. (2017) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2017.04.001 · Cited by 45
Xie, J., Shen, K., Lenchine, R. V., Gethings, L. A., Trim, P. J., Snel, M. F., Zhou, Y., Kenney, J. W., Kamei, M., Kochetkova, M., et al. (2017) · International Journal of Cancer · doi:10.1002/ijc.31210 · Cited by 45
Kenney, J. W., Genheden, M., Moon, K., Wang, X., Foster, L. J., & Proud, C. G. (2016) · Journal of Neurochemistry · doi:10.1111/jnc.13407 · Cited by 44
Oxidized LDL-Mediated Macrophage Survival Involves Elongation Factor-2 Kinase
Chen, J. H., Riazy, M., Smith, E. M., Proud, C. G., Steinbrecher, U. P., & Duronio, V. (2009) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.108.174599 · Cited by 42
Guo, Y., Zhao, Y., Wang, G., Chen, Y., Jiang, Y., Ouyang, L., & Liu, B. (2017) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2017.11.065 · Cited by 42
Zhang, Y., Cheng, Y., Zhang, L., Ren, X., Huber-Keener, K. J., Lee, S. Y., Yun, J. K., Wang, H., & Yang, J. (2011) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2011.09.038 · Cited by 40
Axons in human choroidal melanoma suggest the participation of nerves in the control of these tumors
Seifert, P., & Spitznas, M. (2002) · American Journal of Ophthalmology · doi:10.1016/s0002-9394(02)01329-6 · Cited by 33
MicroRNA-877 acts as a tumor suppressor by directly targeting eEF2K in renal cell carcinoma
Shi, Q., Xu, X., Liu, Q. L., Luo, F., Shi, J., & He, X. (2015) · Oncology Letters · doi:10.3892/ol.2015.4072 · Cited by 31
Wang, H., Zhang, Q., Kong, H., Zeng, Y., Hao, M., Yu, T., Peng, J., Xu, Z., Chen, J., & Shi, H. (2014) · PubMed · Cited by 30
Lazarus, M. B., Levin, R. S., & Shokat, K. M. (2016) · Cellular Signalling · doi:10.1016/j.cellsig.2016.10.006 · Cited by 25
Moore, C. E., da Mota, S. R., Mikolajek, H., & Proud, C. G. (2014) · Molecular and Cellular Biology · doi:10.1128/mcb.00388-14 · Cited by 24
mTORC1 regulates the efficiency and cellular capacity for protein synthesis
Proud, C. G. (2013) · Biochemical Society Transactions · doi:10.1042/bst20130036 · Cited by 24
Mitchell, B., Schumacher, U., Stauber, V. V., & KAISERLING, E. (1994) · European Journal of Cancer · doi:10.1016/0959-8049(94)90465-0 · Cited by 21
Structural Basis for the Recognition of Eukaryotic Elongation Factor 2 Kinase by Calmodulin
Lee, K., Alphonse, S., Piserchio, A., Tavares, C. D. J., Giles, D. H., Wellmann, R. M., Dalby, K. N., & Ghose, R. (2016) · Structure · doi:10.1016/j.str.2016.06.015 · Cited by 21
Xu, Z., Zhao, L., Yang, X., Ma, S., Ge, Y., Liu, Y., Liu, S., Shi, J., & Zheng, D. (2016) · BMC Cancer · doi:10.1186/s12885-016-2288-z · Cited by 19
Impairing Eukaryotic Elongation Factor 2 Kinase Activity Decreases Atherosclerotic Plaque Formation
Zhang, P., Riazy, M., Gold, M., Tsai, S.-H., McNagny, K., Proud, C., & Duronio, V. (2014) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2014.09.019 · Cited by 17
Kameshima, S., Okada, M., Ikeda, S., Watanabe, Y. S., & Yamawaki, H. (2016) · Biochemistry and Biophysics Reports · doi:10.1016/j.bbrep.2016.06.018 · Cited by 17
Monocyte Recruitment Versus Macrophage Proliferation in Atherosclerosis
Kanter, J. E. (2017) · Circulation Research · doi:10.1161/circresaha.117.311973 · Cited by 9
Tumor microenvironment: bidirectional interactions between cancer cells and normal cells
Li, L. (2010) · Protein & Cell · doi:10.1007/s13238-010-0102-2 · Cited by 3
Aşık, E., Kahraman, N., Güray, T., Volkan, M., Lopez‐Berestein, G., & Özpolat, B. (2017) · Cancer Research · doi:10.1158/1538-7445.am2017-1125 · Cited by 1
Zeybek, D. K., Kahraman, N., Bayraktar, R., Kabil, N., Ulukaya, E., Dere, E., Lopez‐Berestein, G., & Özpolat, B. (2018) · ESMO Open · doi:10.1136/esmoopen-2018-eacr25.803 · Cited by 1
Research works printed but not linked: 1
- Tavernarakis N (2013) Protein synthesis. In: Vijg J, Campisi J, Lithgow G (eds) The molecular and cellular biology of aging. Gerontological Society of America (GSA) Press, Washington DC
Cited by
Functionally distinct roles for eEF2K in the control of ribosome availability and p-body abundance
Smith, P. R., Loerch, S., Kunder, N., Stanowick, A. D., Lou, T., & Campbell, Z. T. (2021) · Nature Communications · doi:10.1038/s41467-021-27160-4 · Cited by 58
Ren, Z., Zhang, L., Ding, W., Luo, Y., Shi, Z., Shrestha, B., Kan, X., Zhang, Z., Ding, J., He, H., et al. (2020) · Genomics · doi:10.1016/j.ygeno.2020.11.017 · Cited by 40
Deng, G., Zeng, F., He, Y., Meng, Y., Sun, H., Su, J., Zhao, S., Cheng, Y., Chen, X., & Yin, M. (2022) · Clinical and Translational Medicine · doi:10.1002/ctm2.722 · Cited by 35
The space between notes: emerging roles for translationally silent ribosomes
Smith, P. R., Pandit, S. C., Loerch, S., & Campbell, Z. T. (2022) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2022.02.003 · Cited by 36
Zhang, B., Zou, J., Zhang, Q., Wang, Z., Wang, N., He, S., Zhao, Y., & Naman, C. B. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22052408 · Cited by 31
Metadata
- Authors
- Karakas, D., & Ozpolat, B.
- Affiliations
- The University of Texas MD Anderson Cancer Center (US)
- Corresponding author
- Ozpolat, Bulent
- ORCID
- Ozpolat, Bulent
- Venue
- Journal of Molecular Medicine
- Published
- 2020-05-07
- Volume
- 98
- Issue
- 6
- Pages
- 775-787
- ISSN
- 0946-2716 (ISSN-L)
- 1432-1440
- OpenAlex
- W3023135453
- Cited by
- 54
- References
- 122
- Citations by year
- 2026: 9 · 2025: 16 · 2024: 8 · 2023: 6 · 2022: 8 · 2021: 5 · 2020: 2
- FWCI
- 0.84
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Journal of Molecular Medicine (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer Mechanisms and Therapy
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › PI3K/AKT/mTOR signaling in cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Kinase Regulation and GTPase Signaling
- Keywords
- eEF2K, tumor microenvironment, tumor cell proliferation, epithelial-mesenchymal transition, hypoxia, tumor-associated macrophages, MCP-1, PI3K/Akt signaling, targeted cancer therapy, protein synthesis regulation
- MeSH terms
- Animals, Autophagy, Disease Susceptibility, Enzyme Activation, Humans, Neoplasms, Protein Conformation, Structure-Activity Relationship, Biomarkers, Tumor, Signal Transduction, Gene Expression, Gene Expression Regulation, Neoplastic, Apoptosis, RNA, Untranslated, Protein Kinase Inhibitors, Elongation Factor 2 Kinase, Molecular Targeted Therapy, Tumor Microenvironment
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.